Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients

Bacteria of the genus Aeromonas are widely distributed in water bodies around the world. Some Aeromonas species have been identified as human pathogens causing intestinal and a variety of extraintestinal infections. In Germany, information on diseases caused by Aeromonas is rare, because Aeromonas i...

Full description

Saved in:
Bibliographic Details
Main Authors: Keike Schwartz, Maria Borowiak, Eckhard Strauch, Carlus Deneke, Martin H. Richter, The German Aeromonas Study Group
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2024.1498180/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850113587332251648
author Keike Schwartz
Maria Borowiak
Eckhard Strauch
Carlus Deneke
Martin H. Richter
The German Aeromonas Study Group
author_facet Keike Schwartz
Maria Borowiak
Eckhard Strauch
Carlus Deneke
Martin H. Richter
The German Aeromonas Study Group
author_sort Keike Schwartz
collection DOAJ
description Bacteria of the genus Aeromonas are widely distributed in water bodies around the world. Some Aeromonas species have been identified as human pathogens causing intestinal and a variety of extraintestinal infections. In Germany, information on diseases caused by Aeromonas is rare, because Aeromonas infections are not notifiable in Germany. To address this information gap and gain better insights, a successful collaboration with human medical diagnostic laboratories within Germany was established and several Aeromonas isolates from diseased patients were sent to the Aeromonas laboratory of the German Federal Institute for Risk Assessment. 52 clinical Aeromonas isolates, of which anonymized patients’ data were available, were selected for further characterization by MALDI-TOF MS, biochemical testing, and whole genome sequencing (WGS). Nearly half of the isolates were from patients older than 60 years, whereas only four isolates were from patients aged up to 10 years. 30 isolates originated from stools of patients with diarrhea/(gastro-)enteritis and 22 strains were from patients with diverse extraintestinal infections, such as wound infection, septicemia, bursitis, abscesses, cholangitis, urinary tract infections, and pneumonia. Taxonomical identification revealed following predominant species: A. veronii biovar sobria (18 isolates), A. caviae (17 isolates), and A. hydrophila (nine isolates). Two A. salmonicida isolates and one isolate each of A. dhakensis, A. bestiarum, and A. encheleia were also identified. Three closely related intestinal isolates could not be assigned to a recognized Aeromonas species. The clustering of strains based on virulence factor profile resulted in a grouping that closely resembles the clustering of the phylogenetic tree suggesting that the profiles are specific for each species. Our study on clinical Aeromonas isolates characterizes for the first time human pathogenic strains isolated in Germany. These bacteria are important microorganisms within the One Health context because of their ubiquitous presence in the environment and as a cause of opportunistic infections in humans and animals. Infections caused by Aeromonas bacteria show a seasonality with increased infection rates in warmer periods. In view of climate change, Aeromonas bacteria are regarded as emerging pathogens and research is required to determine the reservoirs in One Health sources from which human infections may arise.
format Article
id doaj-art-c35e0ed26bc24648b1aeccdfabb6d5be
institution OA Journals
issn 1664-302X
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-c35e0ed26bc24648b1aeccdfabb6d5be2025-08-20T02:37:06ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2024-12-011510.3389/fmicb.2024.14981801498180Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patientsKeike SchwartzMaria BorowiakEckhard StrauchCarlus DenekeMartin H. RichterThe German Aeromonas Study GroupBacteria of the genus Aeromonas are widely distributed in water bodies around the world. Some Aeromonas species have been identified as human pathogens causing intestinal and a variety of extraintestinal infections. In Germany, information on diseases caused by Aeromonas is rare, because Aeromonas infections are not notifiable in Germany. To address this information gap and gain better insights, a successful collaboration with human medical diagnostic laboratories within Germany was established and several Aeromonas isolates from diseased patients were sent to the Aeromonas laboratory of the German Federal Institute for Risk Assessment. 52 clinical Aeromonas isolates, of which anonymized patients’ data were available, were selected for further characterization by MALDI-TOF MS, biochemical testing, and whole genome sequencing (WGS). Nearly half of the isolates were from patients older than 60 years, whereas only four isolates were from patients aged up to 10 years. 30 isolates originated from stools of patients with diarrhea/(gastro-)enteritis and 22 strains were from patients with diverse extraintestinal infections, such as wound infection, septicemia, bursitis, abscesses, cholangitis, urinary tract infections, and pneumonia. Taxonomical identification revealed following predominant species: A. veronii biovar sobria (18 isolates), A. caviae (17 isolates), and A. hydrophila (nine isolates). Two A. salmonicida isolates and one isolate each of A. dhakensis, A. bestiarum, and A. encheleia were also identified. Three closely related intestinal isolates could not be assigned to a recognized Aeromonas species. The clustering of strains based on virulence factor profile resulted in a grouping that closely resembles the clustering of the phylogenetic tree suggesting that the profiles are specific for each species. Our study on clinical Aeromonas isolates characterizes for the first time human pathogenic strains isolated in Germany. These bacteria are important microorganisms within the One Health context because of their ubiquitous presence in the environment and as a cause of opportunistic infections in humans and animals. Infections caused by Aeromonas bacteria show a seasonality with increased infection rates in warmer periods. In view of climate change, Aeromonas bacteria are regarded as emerging pathogens and research is required to determine the reservoirs in One Health sources from which human infections may arise.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1498180/fullGermanyAeromonaswhole genome sequencingvirulence gene profileOne Healthclimate change
spellingShingle Keike Schwartz
Maria Borowiak
Eckhard Strauch
Carlus Deneke
Martin H. Richter
The German Aeromonas Study Group
Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients
Frontiers in Microbiology
Germany
Aeromonas
whole genome sequencing
virulence gene profile
One Health
climate change
title Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients
title_full Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients
title_fullStr Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients
title_full_unstemmed Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients
title_short Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients
title_sort emerging aeromonas spp infections in europe characterization of human clinical isolates from german patients
topic Germany
Aeromonas
whole genome sequencing
virulence gene profile
One Health
climate change
url https://www.frontiersin.org/articles/10.3389/fmicb.2024.1498180/full
work_keys_str_mv AT keikeschwartz emergingaeromonassppinfectionsineuropecharacterizationofhumanclinicalisolatesfromgermanpatients
AT mariaborowiak emergingaeromonassppinfectionsineuropecharacterizationofhumanclinicalisolatesfromgermanpatients
AT eckhardstrauch emergingaeromonassppinfectionsineuropecharacterizationofhumanclinicalisolatesfromgermanpatients
AT carlusdeneke emergingaeromonassppinfectionsineuropecharacterizationofhumanclinicalisolatesfromgermanpatients
AT martinhrichter emergingaeromonassppinfectionsineuropecharacterizationofhumanclinicalisolatesfromgermanpatients
AT thegermanaeromonasstudygroup emergingaeromonassppinfectionsineuropecharacterizationofhumanclinicalisolatesfromgermanpatients